New IL-1 family IL-38 is highly expressed in alveolar cells of drug-induced lung injury and idiopathic pulmonary fibrosis

Masaki Tominaga (Kurume, Japan), Masaki Tominaga, Masaki Okamoto, Takashi Kinoshita, Yuki Sakazaki, Masanobu Matsuoka, Shinjiro Kaieda, Tomoaki Hoshino

Source: International Congress 2016 – ILD pathogenesis
Session: ILD pathogenesis
Session type: Poster Discussion
Number: 3088
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Masaki Tominaga (Kurume, Japan), Masaki Tominaga, Masaki Okamoto, Takashi Kinoshita, Yuki Sakazaki, Masanobu Matsuoka, Shinjiro Kaieda, Tomoaki Hoshino. New IL-1 family IL-38 is highly expressed in alveolar cells of drug-induced lung injury and idiopathic pulmonary fibrosis. Eur Respir J 2016; 48: Suppl. 60, 3088

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: The metalloproteinase ADAM8 promotes acute and chronic lung inflammation
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015

Down-regulation of RIP140 can prevent LPS-induced inflammation and acute lung injury in mice via PPARγ
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015

Microvesicles derived from alveolar macrophages mediate epithelial activation via a TNF dependant mechanism
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015

LATE-BREAKING ABSTRACT: Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016



A mouse model of acute lung injury implicates phospholipase Cε in neutrophilic inflammation through CXC chemokine production
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016


TNF and IP-10 drive inflammation into hyperinflammation in the murine lung
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013

Effects of ceramide pathway inhibition on the inflammatory response in lipopolysacharide-triggered lung injury
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015

Preventive and therapeutic treatment with a7 nicotinic receptor agonist reduced lung inflammation and collagen deposition in mice with acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014


The role of SIRT1 in LPS-induced lung endothelial barrier dysfunction and lung injury in vivo
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


Heparin effect in alveolar cells and macrophages in an acute lung injury model
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015

Methotrexate reduces acute lung injury in a murine model of sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016


Cell therapy for the treatment of acute lung injury: Alveolar type II cells or mesenchymal stem cells?
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016

ATP selectively packages TNF within microvesicles released from alveolar macrophages
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016

Long-term effects of nebulized LPS in a mouse model of acute lung injury (ALI)
Source: International Congress 2014 – ILDs 6
Year: 2014

Effects of nebulized heparin on pulmonary inflammation in a rat model of acute lung injury
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015

Hypoxic challenge testing in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Orphan diseases I
Year: 2016


Inhibition of profibrotic signaling in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) by histone deacetylase-inhibitors (HDACi) or the IPF drug pirfenidone
Source: International Congress 2014 – ILDs 1
Year: 2014

Circulating monocytes from interstitial lung disease patients show an activated phenotype
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014


Effects of VAChT reduction on the time course of lung inflammation in mice with acute lung injury
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016